Biomedical Engineering Letters is an interdisciplinary journal dedicated to original investigations in biomedical engineering and applied biophysics.
We are pleased to announce that Biomedical Engineering Letters has been newly included in Science Citation Index Expanded (SCIE) of Web of Science. Consequently, articles published from Volume 9 (2019) onward will be indexed in the Web of Science Core Collection. Further, the journal expects to receive its first Journal Impact Factor (JIF) in the June 2022 release of Journal Citation Reports (JCR). Previously, the journal was added to SCOPUS, PubMedCentral, Emerging Sources Citation Index (ESCI) and many other abstract and citation databases.
The SCIE indexing is a significant milestone for the journal, and would not have been possible without the concerted efforts of many people. We would like to thank all the authors, reviewers, and guest editors for their outstanding support and contribution.
Biomedical Engineering Letters (BMEL) is an official journal of the Korean Society of Medical and Biological Engineering (KOSOMBE). The KOSOMBE is a scientific and professional organization founded in 1979, and a member of International Federation for Medical and Biological Engineering (IFMBE).
Original Articles should contain no more than 6,000 words. This word limit includes all data: title page, abstract, text, disclosure, acknowledgments, key points, references, figure legends, and tables.
A maximum of 8 figures (maximum of 16 parts in total with no more than 4 parts per figure preferred), 8 tables, and 60 references is allowed. A one−paragraph abstract of 150 to 250 words must accompany Original and Review Articles. In the Original Articles, it should state concisely the reason for the study, what was done, what was found, what was concluded, and the relevance.